Document Detail


Anterior ischemic optic neuropathy secondary to interferon alfa.
MedLine Citation:
PMID:  7639655     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To report the occurrence of anterior ischemic optic neuropathy as a complication of treatment with interferon alfa and to consider the possible underlying mechanisms for this association. DESIGN: Description of the clinical findings in two patients with this condition. SETTING: A neuro-ophthalmology referral center. PATIENTS: Two patients, ages 40 and 51 years, undergoing treatment with interferon alfa for malignant neoplasms experienced sudden bilateral, sequential visual loss with disc-related field defects and segmental optic disc edema. INTERVENTIONS: Treatment with aspirin and prednisone in one patient. MAIN OUTCOME MEASURES: Visual acuity, color vision, Goldmann perimetry testing, and fundus photography. RESULTS: Visual loss was mild and generally nonprogressive. The interval between initiating treatment with interferon alfa and onset of anterior ischemic optic neuropathy was similar to that of interferon-associated vascular retinopathy. CONCLUSION: Anterior ischemic optic neuropathy may complicate treatment with interferon alfa. The underlying pathogenesis is probably multifactorial.
Authors:
V A Purvin
Related Documents :
6205625 - Human leukocyte interferon administration to patients with symptomatic and suspected ra...
20600025 - Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with ch...
19039205 - Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 bc...
8860065 - Preliminary results of beta-interferon treatment in the elderly.
24917205 - Feasibility of esophageal reconstruction using a pedicled jejunum with intrathoracic es...
21820095 - Long-term clinical outcomes of percutaneous coronary intervention for chronic total occ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Archives of ophthalmology     Volume:  113     ISSN:  0003-9950     ISO Abbreviation:  Arch. Ophthalmol.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-09-12     Completed Date:  1995-09-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7706534     Medline TA:  Arch Ophthalmol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1041-4     Citation Subset:  AIM; IM    
Affiliation:
Midwest Eye Institute/Methodist Hospital of Indiana, Indianapolis, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Aspirin / therapeutic use
Carcinoma, Renal Cell / therapy
Fundus Oculi
Humans
Interferon-alpha / adverse effects*,  therapeutic use
Ischemia / chemically induced*,  drug therapy
Kidney Neoplasms / therapy
Male
Middle Aged
Multiple Myeloma / therapy
Optic Nerve / blood supply*
Optic Nerve Diseases / chemically induced*,  drug therapy
Prednisone / therapeutic use
Vision Disorders / chemically induced
Visual Acuity
Visual Fields
Chemical
Reg. No./Substance:
0/Interferon-alpha; 50-78-2/Aspirin; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparison of driving in older subjects with and without age-related macular degeneration.
Next Document:  Painful oculomotor palsy caused by posterior-draining dural carotid cavernous fistulas.